News

The feud between OpenAI CEO Sam Altman and onetime cofounder Elon Musk may soon escalate with news that the former is ...
Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...
The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.
The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...